Healthcare cannot achieve its goals for quality, equity, and value without breaking down the persistent barriers that keep critical information siloed across sectors. The post The Next Frontier of Interoperability: Additional Clinical Data Sources – Dentistry, Devices, Social Care, and More appeared first on MedCity News.
The challenge for policymakers is balance: encouraging rigor without unintentionally weakening a program that now serves the majority of Medicare beneficiaries. Thoughtful rate calibration can determine whether this transition strengthens the program or strains it unnecessarily. The post Medicare Advantage’s Discipline Era — and Why the Final Rate Notice Matters More Than It Appears appeared…
Leonard Bighorn said his mother tried for two years to get help for severe stomach pain through the limited health services available near her home on the Fort Peck Reservation in northeastern Montana. After his mom finally saw a specialist in Glasgow, about an hour away, she was diagnosed with stage 4 colon cancer, Bighorn…
Lori Kelley’s deteriorating vision has made it hard for her to find steady work. The 59-year-old, who lives in Harrisburg, North Carolina, closed her nonprofit circus arts school last year because she could no longer see well enough to complete paperwork. She then worked making dough at a pizza shop for a bit. Currently, she…
By JEFF BRANDES To say healthcare’s safety net experienced tectonic shifts in 2025 would be an understatement. The rapid introduction of multiple and massive policy shifts left many healthcare leaders reeling with more questions than answers. As the industry turns the corner into 2026 and the dust begins to settle, it’s time for stakeholders to…
Simple: get people vaccinated. Dr. Oz agrees. The New York Times reports: Dr. Oz, the Centers for Medicare and Medicaid Services director, told CNN on Sunday that there was a simple solution to the raging measles outbreak in South Carolina, which has infected more than 900 people and become the largest U.S. outbreak in recent…
By KIM BELLARD You know, it’s gotten to the point when I just try to tune out the things Robert F. Kennedy Jr. says. “Schizophrenia can be cured with a keto diet”? Sure, whatever. “The war on protein is over”? Who even knew there was such a war? The carnivore diet is a great way…
University of Maryland School of Medicine’s Andreea Creanga, M.D., Ph.D., discusses initiatives to eliminate preventable maternal deaths and severe maternal morbidity
Evommune’s EVO301 met the goals of a placebo-controlled Phase 2a study in atopic dermatitis. The biologic drug neutralizes a signaling protein involved in multiple inflammatory pathways, which could differentiate it from the blockbuster Sanofi and Regeneron Pharmaceuticals immunology drug Dupixent. The post Evommune Starts Making Case to Challenge Dominance of Sanofi’s Dupixent in Atopic Dermatitis…
Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma. The post Lilly’s Chief Information & Digital Officer: AI Use Goes…